Lanean...
Immunomodulation Followed by Antigen-Specific T(reg) Infusion Controls Islet Autoimmunity
Optimal immune-based therapies for type 1 diabetes (T1D) should restore self-tolerance without inducing chronic immunosuppression. CD4(+)Foxp3(+) regulatory T cells (T(regs)) are a key cell population capable of facilitating durable immune tolerance. However, clinical trials with expanded T(regs) in...
Gorde:
| Argitaratua izan da: | Diabetes |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Diabetes Association
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6971488/ https://ncbi.nlm.nih.gov/pubmed/31712320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db19-0061 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|